Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinase

J Antibiot (Tokyo). 1999 Mar;52(3):215-23. doi: 10.7164/antibiotics.52.215.

Abstract

Five new asterriquinone analogs (2-4, 6, 7), together with previously identified neoasterriquinone (1) and isoasterriquinone (5), were isolated from a fermentation broth of the fungus Aspergillus candidus and purified by HSCCC (high speed counter current chromatography) followed by HPLC. The structures were determined by 1D and 2D NMR and MS/MS techniques. All seven showed inhibitory activity against the binding of a recombinant protein containing the SH2 protein domain of Grb-2 to the tyrosine phosphorylated form of the EGF receptor tyrosine kinase. Some of these asterriquinones exhibited specific inhibition of Grb-2 binding compared to Grb-7 and PLC-gamma.

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • Antibiotics, Antineoplastic / isolation & purification
  • Antibiotics, Antineoplastic / metabolism
  • Antibiotics, Antineoplastic / pharmacology*
  • Aspergillus / metabolism*
  • Carrier Proteins / antagonists & inhibitors*
  • Cell Line
  • Chromatography, High Pressure Liquid
  • Enzyme-Linked Immunosorbent Assay
  • ErbB Receptors / metabolism*
  • Fermentation
  • Glutathione Transferase / metabolism
  • Humans
  • Immunoblotting
  • Indoles / isolation & purification
  • Indoles / metabolism
  • Indoles / pharmacology
  • Magnetic Resonance Spectroscopy
  • Phosphorylation
  • Protein Binding
  • Spectrometry, Mass, Fast Atom Bombardment
  • Spectrophotometry, Ultraviolet
  • src Homology Domains

Substances

  • Adaptor Proteins, Signal Transducing
  • Antibiotics, Antineoplastic
  • Carrier Proteins
  • GRAP2 protein, human
  • Indoles
  • asterriquinone
  • Glutathione Transferase
  • ErbB Receptors